Safety and Dose-Finding Study of DTX401 (AAV8G6PC) in Adults With Glycogen Storage Disease Type Ia (GSDIa)
Clinical trial NCT03517085 · COMPLETED
Trial details
- NCT number
- NCT03517085
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-18
- Primary completion
- 2021-11-02
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.